NOHA MAKLAD
Pharmacy at Hartford Tpke, Waterford, CT
License number
Connecticut PCT.0012153
Category
Pharmacy
Type
Pharmacist
Address
Address
900 Hartford Tpke, Waterford, CT 06385
Phone
(860) 442-3300
Professional information
Noha Maklad - Waterford, CT
Work:
PFIZER, INC - Groton, CT
SCIENTIST PFIZER, INC - Groton, CT
SENIOR ASSOCIATE SCIENTIST
SCIENTIST PFIZER, INC - Groton, CT
SENIOR ASSOCIATE SCIENTIST
Education:
UNIVERSITY OF COLORADO - Denver, CO
PHARM.D. BRIGHAM YOUNG UNIVERSITY - Provo, UT
M.SC. in ORGANIC CHEMISTRY ALEXANDRIA UNIVERSITY
B.SC. in PHARMACY
PHARM.D. BRIGHAM YOUNG UNIVERSITY - Provo, UT
M.SC. in ORGANIC CHEMISTRY ALEXANDRIA UNIVERSITY
B.SC. in PHARMACY
Noha Maklad - Waterford, CT
Work:
PFIZER, INC., CNS Department
Scientist PFIZER, INC., CNS Department - Groton, CT
Senior Associate Scientist BRIGHAM YOUNG UNIVERSITY - Provo, UT
Research Assistant BRIGHAM YOUNG UNIVERSITY - Provo, UT
Teaching Assistant AMR PHARMACY, Alexandria, Egypt
Pharmacy Manager AMR PHARMACY, Alexandria, Egypt
Pharmacy Intern
Scientist PFIZER, INC., CNS Department - Groton, CT
Senior Associate Scientist BRIGHAM YOUNG UNIVERSITY - Provo, UT
Research Assistant BRIGHAM YOUNG UNIVERSITY - Provo, UT
Teaching Assistant AMR PHARMACY, Alexandria, Egypt
Pharmacy Manager AMR PHARMACY, Alexandria, Egypt
Pharmacy Intern
Education:
Brigham Young University - Provo, UT
M.Sc. in Organic Chemistry
M.Sc. in Organic Chemistry
Azabenzimidazolyl Compounds
US Patent:
2008031, Dec 18, 2008
Filed:
Jul 20, 2007
Appl. No.:
11/780569
Inventors:
Ivan Efremov - Gales Ferry CT, US
Bruce N. Rogers - Mystic CT, US
Allen J. Duplantier - Ledyard CT, US
Lei Zhang - Waterford CT, US
Qian Zhang - Levittown NY, US
Noha S. Maklad - Waterford CT, US
Bruce N. Rogers - Mystic CT, US
Allen J. Duplantier - Ledyard CT, US
Lei Zhang - Waterford CT, US
Qian Zhang - Levittown NY, US
Noha S. Maklad - Waterford CT, US
International Classification:
A61K 31/437, C07D 471/04, A61P 25/00, A61P 25/18
US Classification:
514303, 546118
Abstract:
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ias defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Heterocyclic Compounds
US Patent:
2009013, May 28, 2009
Filed:
Jun 30, 2008
Appl. No.:
12/165056
Inventors:
Allen J. Duplantier - Ledyard CT, US
Ivan Efremov - Gales Ferry CT, US
Lei Zhang - Waterford CT, US
Noha S. Maklad - Waterford CT, US
Theresa O'Sullivan - Norwich CT, US
Ivan Efremov - Gales Ferry CT, US
Lei Zhang - Waterford CT, US
Noha S. Maklad - Waterford CT, US
Theresa O'Sullivan - Norwich CT, US
International Classification:
A61K 31/536, C07D 265/18, A61P 25/00
US Classification:
5142305, 544 92
Abstract:
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ias defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Benzimidazolyl Compounds
US Patent:
2008028, Nov 13, 2008
Filed:
Jul 20, 2007
Appl. No.:
11/780579
Inventors:
Ivan Efremov - Gales Ferry CT, US
Bruce N. Rogers - Mystic CT, US
Allen J. Duplantier - Ledyard CT, US
Lei Zhang - Waterford CT, US
Qian Zhang - Levittown NY, US
Noha S. Maklad - Waterford CT, US
Edelweiss Evrard - Eastry, GB
Michael A. Brodney - East Lyme CT, US
Bruce N. Rogers - Mystic CT, US
Allen J. Duplantier - Ledyard CT, US
Lei Zhang - Waterford CT, US
Qian Zhang - Levittown NY, US
Noha S. Maklad - Waterford CT, US
Edelweiss Evrard - Eastry, GB
Michael A. Brodney - East Lyme CT, US
International Classification:
C07D 401/02, A61K 31/454, A61K 31/438, C07D 487/10, A61P 25/00
US Classification:
514278, 546199, 514322, 546 18
Abstract:
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ias defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.